|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C12N 15/113 |
| (11) | Patento numeris | 2521783 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 11701706.1 |
| Europos patento paraiškos padavimo data | 2011-01-06 | |
| (97) | Europos patento paraiškos paskelbimo data | 2012-11-14 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2017-08-09 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2011/020298 |
| Data | 2011-01-06 |
| (87) | Numeris | WO 2011/085056 |
| Data | 2011-07-14 |
| (30) | Numeris | Data | Šalis |
| PCT/US2010/0490 | 2010-09-16 | WO | |
| 292878 P | 2010-01-07 | US |
| (72) |
AVKIN-NACHUM, Sharon, IL
FEINSTEIN, Elena, IL
|
| (73) |
Quark Pharmaceuticals, Inc.,
6501 Dumbarton Circle, Fremont, California 94555,
US
|
| (54) | OLIGONUCLEOTIDE COMPOUNDS COMPRISING NON-NUCLEOTIDE OVERHANGS |
| OLIGONUCLEOTIDE COMPOUNDS COMPRISING NON-NUCLEOTIDE OVERHANGS |